Advertisement
Review Article|Articles in Press

Hypersomatotropism and Other Causes of Insulin Resistance in Cats

Published:March 09, 2023DOI:https://doi.org/10.1016/j.cvsm.2023.02.005

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Veterinary Clinics: Small Animal Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Niessen S.J.
        • Powney S.
        • Guitian J.
        • et al.
        Evaluation of a quality-of-life tool for cats with diabetes mellitus.
        J Vet Intern Med. 2010; 24: 1098-1105
        • Niessen S.J.M.
        • Bjornvad C.
        • Church D.B.
        • et al.
        • ESVE/SCE Membership
        Agreeing Language in Veterinary Endocrinology (ALIVE): Diabetes mellitus - a modified Delphi-method-based system to create consensus disease definitions.
        Vet J. 2022; 289: 105910
        • O'Neill D.G.
        • Gostelow R.
        • Orme C.
        • et al.
        Epidemiology of diabetes mellitus among 193,435 cats attending primary-care veterinary practices in England.
        J Vet Intern Med. 2016; 30: 964-972
        • Callegari C.
        • Mercuriali E.
        • Hafner M.
        • et al.
        Survival time and prognostic factors in cats with newly diagnosed diabetes mellitus: 114 cases (2000-2009).
        J Am Vet Med Assoc. 2013; 243: 91-95
        • Gostelow R.
        • Forcada Y.
        • Graves T.
        • et al.
        Systematic review of feline diabetic remission: separating fact from opinion.
        Vet J. 2014; 202: 208-221
        • Niessen S.J.
        • Forcada Y.
        • Mantis P.
        • et al.
        Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter.
        PLoS One. 2015; 10: e0127794
        • Berg R.I.
        • Nelson R.W.
        • Feldman E.C.
        • et al.
        Serum insulin-like growth factor-I concentration in cats with diabetes mellitus and acromegaly.
        J Vet Intern Med. 2007; 21: 892-898
        • Schaefer S.
        • Kooistra H.S.
        • Riond B.
        • et al.
        Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands.
        J Feline Med Surg. 2017; 19: 888-896
        • Scudder C.J.
        • Mirczuk S.M.
        • Richardson K.M.
        • et al.
        Pituitary Pathology and Gene Expression in Acromegalic Cats.
        J Endocr Soc. 2018; 3: 181-200
        • Steele M.M.
        • Borgeat K.
        • Payne J.R.
        • et al.
        Increased insulin-like growth factor 1 concentrations in a retrospective population of non-diabetic cats diagnosed with hypertrophic cardiomyopathy.
        J Feline Med Surg. 2021; 23: 952-958
        • Fletcher J.M.
        • Scudder C.J.
        • Kiupel M.
        • et al.
        Hypersomatotropism in 3 Cats without Concurrent Diabetes Mellitus.
        J Vet Intern Med. 2016; 30: 1216-1221
        • Dirtu A.C.
        • Niessen S.J.
        • Jorens P.G.
        • et al.
        Organohalogenated contaminants in domestic cats' plasma in relation to spontaneous acromegaly and type 2 diabetes mellitus: a clue for endocrine disruption in humans?.
        Environ Int. 2013; 57-58: 60-67
        • Scudder C.J.
        • Niessen S.J.
        • Catchpole B.
        • et al.
        Feline hypersomatotropism and acromegaly tumorigenesis: a potential role for the AIP gene.
        Domest Anim Endocrinol. 2017; 59: 134-139
        • Niessen S.J.
        • Petrie G.
        • Gaudiano F.
        • et al.
        Feline acromegaly: an underdiagnosed endocrinopathy?.
        J Vet Intern Med. 2007; 21: 899-905
        • Borgeat K.
        • Niessen S.J.M.
        • Wilkie L.
        • et al.
        Time spent with cats is never wasted: Lessons learned from feline acromegalic cardiomyopathy, a naturally occurring animal model of the human disease.
        PLoS One. 2018; 13: e0194342
        • Woolhead V.L.
        • Whee Wen L.T.
        • Scudder C.J.
        • et al.
        Serial changes in insulin-like growth factor 1 and impact on hypersomatotropism-screening in feline diabetes mellitus, research communications of the 27th ECVIM-CA congress.
        J Vet Intern Med. 2018; 32: 525-609
      1. Niessen SJ, Khalid M, Petrie G. et al. Validation and application of a radioimmunoassay for ovine growth hormone in the diagnosis of acromegaly in cats, Vet Rec, 2007;160(26):902–907.

        • Kokka N.
        • Garcia J.F.
        • Morgan M.
        • et al.
        Immunoassay of plasma growth hormone in cats following fasting and administration of insulin, arginine, 2-deoxyglucose and hypothalamic extract.
        Endocrinology. 1971; 88: 359-366
        • Slingerland L.I.
        • Voorhout G.
        • Rijnberk A.
        • et al.
        Growth hormone excess and the effect of octreotide in cats with diabetes mellitus.
        Domest Anim Endocrinol. 2008; 35: 352-361
        • Keyte S.V.
        • Kenny P.J.
        • Forcada Y.
        • et al.
        Serum N-Terminal Type III procollagen propeptide: an indicator of growth hormone excess and response to treatment in feline hypersomatotropism.
        J Vet Intern Med. 2016; 30: 973-982
        • Jensen K.B.
        • Forcada Y.
        • Chruch D.B.
        • et al.
        Evaluation and diagnostic potential of serum ghrelin in feline hypersomatotropism and diabetes mellitus.
        J Vet Intern Med. 2015; 29: 14-20
        • Lamb C.R.
        • Ciasca T.C.
        • Mantis P.
        • et al.
        Computed tomographic signs of acromegaly in 68 diabetic cats with hypersomatotropism.
        J Feline Med Surg. 2014; 16: 99-108
        • Fenn J.
        • Kenny P.J.
        • Scudder C.J.
        • et al.
        Efficacy of hypophysectomy for the treatment of hypersomatotropism-induced diabetes mellitus in 68 cats.
        J Vet Intern Med. 2021; 35: 823-833
        • Van Bokhorst K.L.
        • Galac S.
        • Kooistra H.S.
        • et al.
        Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats.
        J Vet Intern Med. 2021; 35: 834-842
        • Neilson D.M.
        • Viscasillas J.
        • Alibhai H.I.
        • et al.
        Anaesthetic management and complications during hypophysectomy in 37 cats with acromegaly.
        J Feline Med Surg. 2019; 21: 347-352
        • Watson-Skaggs M.L.
        • Gieger T.L.
        • Yoshikawa H.
        • et al.
        Endocrine response and outcome in 14 cats with insulin resistance and acromegaly treated with stereotactic radiosurgery (17 Gy).
        Am J Vet Res. 2021; 83: 64-71
        • Gostelow R.
        • Scudder C.
        • Keyte S.
        • et al.
        Pasireotide long-acting release treatment for diabetic cats with underlying hypersomatotropism.
        J Vet Intern Med. 2017; 31: 355-364
        • Miceli D.D.
        • Vidal P.N.
        • Pompili G.A.
        • et al.
        Diabetes mellitus remission in three cats with hypersomatotropism after cabergoline treatment.
        JFMS Open Rep. 2021; 7 (20551169211018991)
        • Scudder C.J.
        • Hazuchova K.
        • Gostelow R.
        • et al.
        Pilot study assessing the use of cabergoline for the treatment of cats with hypersomatotropism and diabetes mellitus.
        J Feline Med Surg. 2021; 23: 131-137
        • Blois S.L.
        • Holmberg D.L.
        Cryohypophysectomy used in the treatment of a case of feline acromegaly.
        J Small Anim Pract. 2008; 49: 596-600
        • Corsini A.
        • Niessen S.J.
        • Miceli D.D.
        • et al.
        Quality of life and response to treatment in cats with hypersomatotropism: the owners' point of view.
        J Feline Med Surg. 2022; 24: e175-e182
        • Niessen S.J.
        • Church D.B.
        • Forcada Y.
        Hypersomatotropism, acromegaly, and hyperadrenocorticism and feline diabetes mellitus.
        Vet Clin North Am Small Anim Pract. 2013; 43: 319-350
        • Gilor C.
        • Niessen S.J.
        • Furrow E.
        • et al.
        What's in a Name? Classification of Diabetes Mellitus in Veterinary Medicine and Why It Matters.
        J Vet Intern Med. 2016; 30: 927-940
        • McCann T.M.
        • Simpson K.E.
        • Shaw D.J.
        • et al.
        Feline diabetes mellitus in the UK: the prevalence within an insured cat population and a questionnaire-based putative risk factor analysis.
        J Feline Med Surg. 2007; 9: 289-299
        • Harro C.C.
        • Refsal K.R.
        • Shaw N.
        • et al.
        Retrospective study of aldosterone and progesterone secreting adrenal tumors in 10 cats.
        J Vet Intern Med. 2021; 35: 2159-2166
        • Valentin S.Y.
        • Cortright C.C.
        • Nelson R.W.
        • et al.
        Clinical findings, diagnostic test results, and treatment outcome in cats with spontaneous hyperadrenocorticism: 30 cases.
        J Vet Intern Med. 2014; 28: 481-487
        • Combes A.
        • Pey P.
        • Paepe D.
        • et al.
        Ultrasonographic appearance of adrenal glands in healthy and sick cats.
        J Feline Med Surg. 2013; 15: 445-457
        • Bertazzolo W.
        • Didier M.
        • Gelain M.E.
        • et al.
        Accuracy of cytology in distinguishing adrenocortical tumors from pheochromocytoma in companion animals.
        Vet Clin Pathol. 2014; 43: 453-459
        • Mellett Keith A.M.
        • Bruyette D.
        • Stanley S.
        Trilostane therapy for treatment of spontaneous hyperadrenocorticism in cats: 15 cases (2004-2012).
        J Vet Intern Med. 2013; 27: 1471-1477
        • Muschner A.C.
        • Varela F.V.
        • Hazuchova K.
        • et al.
        Diabetes mellitus remission in a cat with pituitary-dependent hyperadrenocorticism after trilostane treatment.
        JFMS Open Rep. 2018; 4 (2055116918767708)
        • Miceli D.D.
        • Zelarayán G.S.
        • García J.D.
        • et al.
        Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment.
        JFMS Open Rep. 2021; 7 (20551169211029896)
        • Meij B.P.
        • Voorhout G.
        • Van Den Ingh T.S.
        • et al.
        Transsphenoidal hypophysectomy for treatment of pituitary-dependent hyperadrenocorticism in 7 cats.
        Vet Surg. 2001; 30: 72-86
        • Duesberg C.A.
        • Nelson R.W.
        • Feldman E.C.
        • et al.
        Adrenalectomy for treatment of hyperadrenocorticism in cats: 10 cases (1988-1992).
        J Am Vet Med Assoc. 1995; 207: 1066-1070
        • Daniel G.
        • Mahony O.M.
        • Markovich J.E.
        • et al.
        Clinical findings, diagnostics and outcome in 33 cats with adrenal neoplasia (2002-2013).
        J Feline Med Surg. 2016; 18: 77-84